Vaxess Technologies has filed a notice of an exempt offering of securities to raise $12,000,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Vaxess Technologies is raising up to $12,000,000.00 in new funding. Sources indicate that as part of senior management President, Rachel Sha played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Vaxess Technologies
Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform. We are committed to improving access to vaccines by enabling better, more stable vaccine products that can be easily delivered all over the world. Find more information at www.vaxess.com.
To learn more about Vaxess Technologies, visit http://www.vaxess.com/
Contact:
Rachel Sha, President
617-306-3831
https://www.linkedin.com/in/rachelsha/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.